NIH VideoCast - Hepatitis C and beyond: Never a dull moment

Skip Navigation

Hepatitis C and beyond: Never a dull moment

Loading... Loading video...

332 Views

Air date:	Wednesday, June 8, 2016, 3:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 332 (101 Live, 231 On-demand)
Category:	WALS - Wednesday Afternoon Lectures
Runtime:	01:03:03
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	NIH Director’s Wednesday Afternoon Lecture Series The Annual George Khoury Lecture From the emergence of a mystery virus associated with post-transfusion hepatitis to the discovery of the hepatitis C virus (HCV), we are now witnessing a remarkable new era of highly effective, curative treatments. Despite this, challenges remain to effectively implement these medical advances on a national and global scale. For the molecular virologist, many questions remain unanswered. Why are clinical isolates of HCV so difficult to culture? What is the link between chronic HCV and liver cancer? Where did HCV come from and should we rest on our laurels assuming that hepacivirus-associated disease will soon vanish? These and other topics will be the subject of this Khoury lecture. For more information go to https://oir.nih.gov/wals

NLM Title:	Hepatitis C and beyond : never a dull moment / Charles M. Rice.
Author:	Rice, C M. National Institutes of Health (U.S.),
Publisher:
Abstract:	(CIT): NIH Director's Wednesday Afternoon Lecture Series The Annual George Khoury Lecture From the emergence of a mystery virus associated with post-transfusion hepatitis to the discovery of the hepatitis C virus (HCV), we are now witnessing a remarkable new era of highly effective, curative treatments. Despite this, challenges remain to effectively implement these medical advances on a national and global scale. For the molecular virologist, many questions remain unanswered. Why are clinical isolates of HCV so difficult to culture? What is the link between chronic HCV and liver cancer? Where did HCV come from and should we rest on our laurels assuming that hepacivirus-associated disease will soon vanish? These and other topics will be the subject of this Khoury lecture.
Subjects:	Antiviral Agents--therapeutic use Hepacivirus--genetics Hepacivirus--immunology Hepatitis C--drug therapy Hepatitis C--genetics Hepatitis C--immunology
Publication Types:	Lecture Webcast

NLM Classification:	WC 536
NLM ID:	101686952
CIT Live ID:	19251
Permanent link:	https://videocast.nih.gov/watch=19251

Related Videos...